These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2662351)
61. Transfusion-induced malaria. Plasmodium vivax in a 5-month-old child. Seeler RA; Miller RA; Lin CH; Lin SK Am J Dis Child; 1973 Jan; 125(1):132-3. PubMed ID: 4567359 [No Abstract] [Full Text] [Related]
62. Fluorescent-antibody patterns in naturally acquired vivax malaria. Fisher GU; Sulzer AJ; Wilson M; Runcik K Am J Trop Med Hyg; 1970 Mar; 19(2):209-14. PubMed ID: 4910775 [No Abstract] [Full Text] [Related]
63. Malaria in a Honduras hunter. Chanbusarakum P; Gelb L South Med J; 1978 Jan; 71(1):74-5. PubMed ID: 341334 [No Abstract] [Full Text] [Related]
64. Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries. Quashie NB; Duah-Quashie NO J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33367880 [TBL] [Abstract][Full Text] [Related]
66. Mixed malarial infection due to Plasmodium falciparum and P vivax. Gilks C; Pasvol G; Juel-Jensen B Br Med J (Clin Res Ed); 1985 Aug; 291(6495):603-4. PubMed ID: 3929891 [No Abstract] [Full Text] [Related]
67. A note on an interesting case of treatment of Plasmodium vivax curative therapy relapses in a four year old child from Aurangabad, Maharashtra State, India. Vittal M; Bhate MR; Shinde PH; Deshpande SV Indian J Med Sci; 1982 Mar; 36(3):64-6. PubMed ID: 6757134 [No Abstract] [Full Text] [Related]
68. Morphological changes in lasmodium vivax in patients under treatment with chloroquine. Jeffrey HC Trans R Soc Trop Med Hyg; 1968; 62(1):47-50. PubMed ID: 4170613 [No Abstract] [Full Text] [Related]
70. Effects of diaphenylsulphone (dapsone) against Plasmodium vivax of South West Pacific origin. Rieckmann KH; Brewer GJ; Powell RD Trans R Soc Trop Med Hyg; 1968; 62(5):649-53. PubMed ID: 4387731 [No Abstract] [Full Text] [Related]
71. Recurrent plasmodium ovale infection from Papua New Guinea--chloroquine resistance or inadequate primaquine therapy? Nathwani D; Currie PF; Smith CC; Khaund R J Infect; 1991 Nov; 23(3):343-4. PubMed ID: 1753151 [No Abstract] [Full Text] [Related]
72. Malaria in the emergency department. Stair T; Ricci R; Pedicano J; Kane J Ann Emerg Med; 1983 Jul; 12(7):422-5. PubMed ID: 6349433 [TBL] [Abstract][Full Text] [Related]
74. Clinical experience on malaria. Chang TJ; Chiang PC; Chen TP; Hwang KP; Chen ER Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 May; 7(5):285-90. PubMed ID: 2056563 [TBL] [Abstract][Full Text] [Related]
75. Lack of effect of antimalarial prophylaxis with chloroquine or amodiaquine in cutaneous leishmaniasis in French Guiana. Dedet JP; Esterre P Trans R Soc Trop Med Hyg; 1986; 80(3):490. PubMed ID: 3798549 [No Abstract] [Full Text] [Related]
76. Changes in serum lipoproteins during malariatherapy with Plasmodium vivax. Maurois P; Vernes A; Charet P; Nouvelot A; Becquet R; Giard R Ann Trop Med Parasitol; 1979 Oct; 73(5):491-3. PubMed ID: 393192 [No Abstract] [Full Text] [Related]
77. Antibody production in Plasmodium vivax infections suppressed by weekly doses of chloroquine. Lunn JS; Jacobs RL; Contacos PG; Coatney GR Am J Trop Med Hyg; 1965 Sep; 14(5):697-9. PubMed ID: 5318565 [No Abstract] [Full Text] [Related]
78. Relapse after standard treatment of malaria. Wiseman RA Br Med J; 1970 May; 2(5705):365. PubMed ID: 5429469 [No Abstract] [Full Text] [Related]
79. Methotrexate therapy for P vivax malaria. Ferone R JAMA; 1971 Jan; 215(1):117. PubMed ID: 4924742 [No Abstract] [Full Text] [Related]